Press release
Europe Gene Therapy Market Set to Record US$ 8,780.77 Million by 2033., Growth Surge by - CRISPR Therapeutics, BioMarin Pharmaceutical Inc., MeiraGTx Holdings plc, and PTC Therapeutics, Inc
Europe Gene Therapy Market Size 2026
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/europe-gene-therapy-market?kb
Europe Gene Therapy: Recent Industry Developments
✅ March 2026: uniQure advanced its AAV-based gene therapy pipeline with continued focus on neurological and rare genetic disorders, strengthening its late-stage clinical portfolio in Europe.
✅ February 2026: Oxford Biomedica expanded viral vector manufacturing capacity to support increasing demand from global gene therapy developers and accelerate commercial-scale production capabilities.
✅ January 2026: Orchard Therapeutics (UK-origin CGT leader) progressed next-generation ex vivo gene therapy programs targeting rare inherited blood disorders, reinforcing Europe's leadership in rare disease treatment innovation.
✅ December 2025: Freeline Therapeutics strengthened its AAV-based liver-targeted gene therapy platform through strategic R&D expansion and partnerships aimed at improving long-term therapeutic durability.
Capitalize on high-growth Europe Gene Therapy opportunities. Connect with verified partners and make informed expansion decisions: https://www.datamintelligence.com/partner-identification-enquiry/europe-gene-therapy-market?kb
List of Top Key Players 2026:
Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc., Krystal Biotech, Inc., CSL, Bluebird Bio, Inc., SPARK THERAPEUTICS, INC., Ferring, Vertex Pharmaceuticals Incorporated, Amgen, Inc., Orchard Therapeutics Plc, CRISPR Therapeutics, BioMarin Pharmaceutical Inc., MeiraGTx Holdings plc, and PTC Therapeutics, Inc
Growth Forecast Projected 2026-2033:
The Europe Gene Therapy Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Industry Developments 2025-2026:
✅ April 2026: Biopharmaceutical companies in Europe accelerated late-stage clinical trials for AAV and CRISPR-based gene therapies targeting rare genetic disorders and oncology indications, supported by improved regulatory alignment under EMA frameworks.
✅ February 2026: Strategic collaborations expanded between European biotech firms and global pharmaceutical companies to enhance manufacturing capacity for viral vectors and scale up gene therapy production infrastructure.
✅ January 2026: Increased regulatory approvals and fast-track designations were granted for next-generation gene therapy candidates addressing inherited retinal diseases and neuromuscular disorders.
✅ December 2025: Investments in advanced cell and gene therapy manufacturing facilities increased across key European hubs to address supply constraints and improve vector production efficiency.
✅ November 2025: Clinical pipeline expansion continued with rising focus on in vivo gene editing technologies, particularly CRISPR and base-editing platforms for rare disease treatment.
✅ October 2025: Academic-industry partnerships strengthened across Europe to accelerate translational research, improving early-stage development of gene therapies and biomarker-driven patient selection.
How Our Market Research Process Works:
The Europe Gene Therapy Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Europe Gene Therapy ecosystem.
Latest Mergers & Acquisitions (M & A) 2025-2026:
• April 2026: LEO Pharma acquired Replay's gene therapy platform focused on rare genetic skin diseases, strengthening its dermatology and gene therapy pipeline.
• April 2026: MeiraGTx signed an asset purchase agreement with Johnson & Johnson to acquire botaretigene sparoparvovec (bota-vec) gene therapy for X-linked retinitis pigmentosa.
• February 2026: Swedish private equity firm EQT Group withdrew its takeover bid for UK-based cell and gene therapy manufacturer Oxford Biomedica after multiple proposals were rejected.
• January 2026: Sanofi made a €20 million strategic investment in French gene therapy biotech Sensorion to support development of genetic hearing loss therapies.
• January 2026: Eli Lilly and Company entered a deal worth up to US$1.12 billion with German gene-editing company Seamless Therapeutics to develop next-generation gene editing therapies for hearing loss.
Unlock & Get Full 360° Best Strategic Market Report: https://www.datamintelligence.com/buy-now-page?report=europe-gene-therapy-market?kb
Major Focused Key Segmentation (2026):
By Approach: In-Vivo, Ex vivo
By Vector Type: Viral Vectors, Non-Viral Vectors
By Technique: Gene Addition, Gene Silencing, Gene Editing
By Application: Rare Diseases, Musculoskeletal Conditions, Blood Disorders, Oncology, Ophthalmology, Others
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Request Strategic Growth Market Customization: https://datamintelligence.com/customize/europe-gene-therapy-market?kb
FAQ
Q1: What is the present market size and value of the Europe Gene Therapy Market?
A: The Europe Gene Therapy Market was valued at US$ 1,030.70 Million in 2024 and is projected to reach US$ 8,780.77 Million by 2033, growing steadily over the forecast period.
Q2: How fast is the market expected to grow?
A: The Europe Gene Therapy market is expected to register a strong CAGR of 24.9 % during the 2025-2033
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Gene Therapy Market Set to Record US$ 8,780.77 Million by 2033., Growth Surge by - CRISPR Therapeutics, BioMarin Pharmaceutical Inc., MeiraGTx Holdings plc, and PTC Therapeutics, Inc here
News-ID: 4505990 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Smart Farming Market Set for Steady Growth to US$ 26.75 Billion by 2033, Led by …
DataM Intelligence has released a new research report titled "Smart Farming Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
Future of Japan Hospital Outsourcing Services Market Set to Reacord US$ 27.7 Bil …
The Japan hospital outsourcing services market is experiencing strong structural expansion driven by rising healthcare cost pressures, workforce shortages, and increasing demand for operational efficiency across medical institutions. The market is projected to grow from US$ 9.4 Billion in 2024 to US$ 10.6 Billion in 2025, and is expected to reach US$ 27.7 Billion by 2033, expanding at a CAGR of 12.8% (2026-2033) as hospitals increasingly shift toward specialized outsourcing…
Neutropenia Treatment Market to Reach USD 26.46 Billion by 2033 at 5.6% CAGR; No …
The global Neutropenia Treatment market was valued at USD 16.25 billion in 2025 and is projected to reach USD 26.46 billion by 2033, growing at a CAGR of 5.6% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of cancer and chemotherapy-induced neutropenia, rising incidence of autoimmune disorders, and growing demand for effective infection prevention therapies. Expanding oncology treatment volumes…
Metrorrhagia Treatment Market to Reach USD 1,246.56 Million by 2033 at 6.9% CAGR …
The global Metrorrhagia Treatment market was valued at USD 896.36 million in 2025 and is projected to reach USD 1,246.56 million by 2033, growing at a CAGR of 6.9% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of abnormal uterine bleeding, rising awareness regarding women's health issues, and growing demand for effective hormonal and non-hormonal treatment options. Increasing incidence…
More Releases for Europe
2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends
Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging…
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business.
A new report as a Digital Strategy Consulting market that includes a comprehensive analysis…
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• McKinsey
• The Boston Consulting Group
• Bain & Company
• Booz & Co.
• Roland Berger Europe
• Oliver Wyman Europe
• A.T. Kearney Europe
• Deloitte
• Accenture Europe
Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB
Market segment by Type, the product can be split into
• Operations Consultants
• Business Strategy Consultants
• Investment Consultants
• Sales and…
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage.
The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China.
In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
